SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis
Background: Tauroselcholic [75selenium] acid (SeHCAT™) (GE Healthcare, Chicago, IL, USA) is a radiopharmaceutical that may be useful in diagnosing bile acid diarrhoea. Objectives: To assess the clinical effectiveness and cost-effectiveness of SeHCAT for the investigation of adults with chronic unexp...
Main Authors: | Marie Westwood, Isaac Corro Ramos, Nigel Armstrong, Edyta Ryczek, Hannah Penton, Marscha Holleman, Caro Noake, Maiwenn Al |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2022-11-01
|
Series: | Health Technology Assessment |
Subjects: | |
Online Access: | https://doi.org/10.3310/JTFO0945 |
Similar Items
-
Congenital diarrhoea in a neonate with hypernatraemia and dehydration
by: Ammara Kaleem, et al.
Published: (2023-10-01) -
A single faecal bile acid stool test demonstrates potential efficacy in replacing SeHCAT testing for bile acid diarrhoea in selected patients
by: Aditi Kumar, et al.
Published: (2022-05-01) -
Manipulating the Microbiome: An Alternative Treatment for Bile Acid Diarrhoea
by: Evette B. M. Hillman, et al.
Published: (2021-04-01) -
Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report
by: Orkun Aydin, et al.
Published: (2018-01-01) -
The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
by: Aditi Kumar, et al.
Published: (2023-03-01)